Adaptimmune Company
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Investors
%20.jpg)
Total Funding:
$249.5M
Headquarters:
Oxton, York, United Kingdom
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
Less than $1M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
P4 Medicine
Investor Type:
Company
Investors Number:
14
Founded Date:
2008
Industry:
Genomic and Epigenominc Instabillity